M&A Deal Summary

Apollo Endosurgery Acquires Allergan - Obesity Intervention Division

On December 2, 2013, Apollo Endosurgery acquired medical products company Allergan - Obesity Intervention Division from Allergan for 110M USD

Acquisition Highlights
  • This is Apollo Endosurgery’s 1st transaction in the Medical Products sector.
  • This is Apollo Endosurgery’s 2nd largest (disclosed) transaction.
  • This is Apollo Endosurgery’s 2nd transaction in the United States.
  • This is Apollo Endosurgery’s 1st transaction in California.

M&A Deal Summary
Date 2013-12-02
Target Allergan - Obesity Intervention Division
Sector Medical Products
Buyer(s) Apollo Endosurgery
Sellers(s) Allergan
Deal Type Divestiture
Deal Value 110M USD

Target

Allergan - Obesity Intervention Division

Irvine, California, United States
Allergan, Inc. - Obesity Intervention Division is a manufacturer and sells weight loss solutions comprised of the LAP-BAND® adjustable gastric banding system and the ORBERA™ intra-gastric balloon system.

Search 199,442 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Apollo Endosurgery

Austin, Texas, United States
Category Company
Founded 2005
Sector Medical Products
DESCRIPTION

Apollo Endosurgery, Inc. (old) is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 500 million people globally, as well as other gastrointestinal disorders.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 1 of 1
Type (Divestiture) 2 of 2
State (California) 1 of 1
Country (United States) 2 of 2
Year (2013) 2 of 2
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-29 Lap-Band System

United States

The lap-band procedure, which involves inserting a band around a portion of the stomach to reduce its capacity and restrict the amount of food a patient can consume.

Buy $110M

Seller(S) 1

SELLER

Allergan

Irvine, California, United States
Category Company
Founded 1948
Sector Life Science
Employees11,400
DESCRIPTION

Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.

DEAL STATS #
Overall 2 of 3
Sector (Medical Products) 1 of 1
Type (Divestiture) 2 of 3
State (California) 1 of 2
Country (United States) 2 of 3
Year (2013) 2 of 2
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-29 Lap-Band System

United States

The lap-band procedure, which involves inserting a band around a portion of the stomach to reduce its capacity and restrict the amount of food a patient can consume.

Sell $110M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-27 Allergan Generics

California, United States

Allergan Generics is the generic drugs unit of Allergen Inc.

Sell $40.5B
Mergr

Product

Company

Legal